Maven Clinic acquires digital health company Naytal to accelerate UK expansion

Maven Clinic has acquired the London-based digital health company Naytal to accelerate its growth in the UK and Europe.

The virtual clinic, which partners with employers to reduce costs of care and improve clinical outcomes, has more than 70 employer UK clients with employees in the region.

The acquisition of Naytal is hoped to enhance its ability to serve its members in the UK and provide families with access to personalised care.

“Maven’s digital platform has been built to address gaps in reproductive and maternal health globally and meet each member, no matter where they are in the world, with the same level of high-quality, personalised care,” said Kate Ryder, founder and CEO of Maven Clinic.

“With our acquisition of Naytal, our rapidly expanding UK and European membership will have even greater access to timely support that meets their unique needs through a partner deeply embedded in the region.”

Leila Thabet, founder and CEO of Naytal, said: “Women’s health is universally misunderstood and women and families around the world are too often let down by the healthcare systems designed to support them.

“Maven has set the standard and paved the way for innovation for women’s and family healthcare globally and was an inspiration for me when I started Naytal.

“I am thrilled to be joining Kate and the team on their mission to provide better access to quality healthcare for women and families in the UK and throughout Europe.”

Founded in 2021 by entrepreneur Leila Thabet, Naytal provides on-demand access to women’s and family health experts to support a range of reproductive healthcare needs, including fertility and pregnancy care as well as menopause.

Thabet, the company’s founder and CEO, will join Maven as regional vice president, global growth and partnerships, and many of Naytal’s UK-based women’s health providers will join Maven’s network of providers around the world.

In November, Maven raised US$90m in funding to invest in personalisation across its reproductive health platform, bringing its total funding to US$300m. 

The platform allows its members to access local support through care advocates who understand the cultural and regulatory context of each region, specialists aligned to member needs, culture, language and time zone, and local steerage to in-person care.